Cargando…

Single-dose VSV-based vaccine protects cynomolgus macaques from disease after Taï Forest virus infection

Taï Forest virus (TAFV) is a lesser-known ebolavirus that causes lethal infections in chimpanzees and is responsible for a single human case. Limited research has been done on this human pathogen; however, with the recent emergence of filoviruses in West Africa, further investigation and countermeas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fletcher, Paige, O’Donnell, Kyle L., Doratt, Brianna M., Malherbe, Delphine C., Clancy, Chad S., Rhoderick, Joseph F., Feldmann, Friederike, Hanley, Patrick W., Ksiazek, Thomas G., Geisbert, Thomas W., Messaoudi, Ilhem, Marzi, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Ebola
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392270/ https://www.ncbi.nlm.nih.gov/pubmed/37470396 http://dx.doi.org/10.1080/22221751.2023.2239950

Ejemplares similares

Distinct transcriptional responses to fatal Ebola virus infection in cynomolgus and rhesus macaques suggest species-specific immune responses
por: Pinski, Amanda N., et al.
Publicado: (2021)

Transcriptional profiling of immune responses in NHPs after low-dose, VSV-based vaccination against Marburg virus
por: Prator, Cecilia A., et al.
Publicado: (2023)

Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques
por: Woolsey, Courtney, et al.
Publicado: (2022)

Recombinant Sudan virus and evaluation of humoral cross-reactivity between Ebola and Sudan virus glycoproteins after infection or rVSV-ΔG-ZEBOV-GP vaccination
por: Kainulainen, Markus H., et al.
Publicado: (2023)

Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge
por: Marzi, Andrea, et al.
Publicado: (2019)

Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease
por: Marzi, Andrea, et al.
Publicado: (2021)

Ebola virus inclusion bodies are liquid organelles whose formation is facilitated by nucleoprotein oligomerization
por: Bodmer, Bianca S., et al.
Publicado: (2023)

N(6)-methyladenosine is required for efficient RNA synthesis of Ebola virus and other haemorrhagic fever viruses
por: Wendt, Lisa, et al.
Publicado: (2023)

Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection in vitro
por: Kummer, Susann, et al.
Publicado: (2022)

In vivo characterization of the novel ebolavirus Bombali virus suggests a low pathogenic potential for humans
por: Bodmer, B. S., et al.
Publicado: (2023)

Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain
por: Marzi, Andrea, et al.
Publicado: (2015)

Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection
por: Menicucci, Andrea R., et al.
Publicado: (2019)

Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-based vaccine
por: O'Donnell, Kyle L., et al.
Publicado: (2023)

Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation
por: Marzi, Andrea, et al.
Publicado: (2019)

Transcriptomic analysis reveals a previously unknown role for CD8(+) T-cells in rVSV-EBOV mediated protection
por: Menicucci, Andrea R., et al.
Publicado: (2017)

Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus
por: Mire, Chad E., et al.
Publicado: (2016)

Pathogenesis of lassa fever in cynomolgus macaques
por: Hensley, Lisa E, et al.
Publicado: (2011)

Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2016)

Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs
por: de Wit, Emmie, et al.
Publicado: (2015)

Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses
por: Qiu, Xiangguo, et al.
Publicado: (2009)

Ebola and the eye
por: Clare, Gerry
Publicado: (2020)

Transcriptional response to VZV infection is modulated by RNA polymerase III in lung epithelial cell lines
por: Doratt, Brianna M., et al.
Publicado: (2022)

Single-dose VSV-based vaccine protects against Kyasanur Forest disease in nonhuman primates
por: Bhatia, Bharti, et al.
Publicado: (2023)

SARS-Cov-2 Infection and Seroconversion Rates in Healthcare Providers Prior to COVID-19 Vaccine Rollout
por: Shin, Sanghyuk S., et al.
Publicado: (2023)

To B or Not to B: Mechanisms of Protection Conferred by rVSV-EBOV-GP and the Roles of Innate and Adaptive Immunity
por: Pinski, Amanda N., et al.
Publicado: (2020)

Recently Emerged Swine Influenza A Virus (H2N3) Causes Severe Pneumonia in Cynomolgus Macaques
por: Richt, Juergen A., et al.
Publicado: (2012)

Optimization of single dose VSV-based COVID-19 vaccination in hamsters
por: O’Donnell, Kyle L., et al.
Publicado: (2021)

Optimization of Single-Dose VSV-Based COVID-19 Vaccination in Hamsters
por: O’Donnell, Kyle L., et al.
Publicado: (2022)

Species-specific immunogenicity and protective efficacy of a vesicular stomatitis virus-based Sudan virus vaccine: a challenge study in macaques
por: Marzi, Andrea, et al.
Publicado: (2023)

Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins
por: O’Donnell, Kyle L., et al.
Publicado: (2022)

Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses
por: Lehrer, Axel T., et al.
Publicado: (2021)

Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
por: Marzi, Andrea, et al.
Publicado: (2015)

Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a recombinant vaccine
por: Furuyama, Wakako, et al.
Publicado: (2021)

Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine
por: Furuyama, Wakako, et al.
Publicado: (2022)

Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment
por: Cross, Robert W., et al.
Publicado: (2020)

Comparative Pathogenesis of Three Human and Zoonotic SARS-CoV Strains in Cynomolgus Macaques
por: Rockx, Barry, et al.
Publicado: (2011)

Mild/Asymptomatic Maternal SARS-CoV-2 Infection Leads to Immune Paralysis in Fetal Circulation and Immune Dysregulation in Fetal-Placental Tissues
por: Doratt, Brianna M., et al.
Publicado: (2023)

Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection
por: Marzi, Andrea, et al.
Publicado: (2016)

SARS-CoV-2 Vaccine Booster Elicits Robust Prolonged Maternal Antibody Responses and Passive Transfer Via The Placenta And Breastmilk
por: MARSHALL, Nicole E., et al.
Publicado: (2022)

VSV-Based Vaccines Reduce Virus Shedding and Viral Load in Hamsters Infected with SARS-CoV-2 Variants of Concern
por: O’Donnell, Kyle L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_km6c6anc4lf4ivum63m8h0iaku